The FDA's Impediment to Healthcare Innovation and a Nationwide Tour Announcement

This chapter delves into the criticism of the FDA as an unelected authority that impedes healthcare innovation, leading to increased costs. The discussion also highlights an upcoming nationwide tour that offers listeners a chance to engage with a media figure while supporting grassroots initiatives.